Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.19 USD | +11.38% | +16.03% | -4.96% |
05-02 | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
05-02 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.96% | 1.53B | |
+73.17% | 12.38B | |
-18.08% | 7.99B | |
+16.24% | 7.21B | |
+3.39% | 5.79B | |
+11.77% | 5.35B | |
+29.65% | 4.63B | |
-17.74% | 4.17B | |
-35.34% | 2.44B | |
+2.10% | 2.03B |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Wedbush Cuts NovoCure's Price Target to $45 From $85, Says 'Revenues Have Flat-Lined;' Underperform Rating Kept